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Background: Primary care physicians provide palliative home care. In cancer patients dying at home in the
Netherlands (45% of all cancer patients) euthanasia in about one out of every seven patients indicates unbearable
suffering. Symptom prevalence, relationship between intensity of symptoms and unbearable suffering, evolvement
of symptoms and unbearability over time and quality of unbearable suffering were studied in end-of-life cancer
patients in primary care.
Methods: 44 general practitioners during three years recruited cancer patients estimated to die within six months.
Every two months patients quantified intensity as well as unbearability of 69 symptoms with the State-of-Suffering-
V (SOS-V). Also overall unbearable suffering was quantified. The five-point rating scale ranged from 1 (not at all) to 5
(hardly can be worse). For symptoms assessed to be unbearable the nature of the suffering was additionally investigated
with open-ended questions. The final interviews were analyzed; for longitudinal evolvement also the pre-final interviews
were analyzed. Symptom intensity scores 4 and 5 were defined to indicate high intensity. Symptom unbearability scores
4 and 5 were defined to indicate unbearable suffering. Two raters categorized the qualitative descriptions of unbearable
suffering.
Results: Out of 148 requested patients 51% participated; 64 patients were followed up until death. The SOS-V was
administered at least once in 60 patients (on average 30 days before death) and at least twice in 33 patients.
Weakness was the most frequent unbearable symptom (57%). Pain was unbearable in 25%. Pain, loss of control over
one’s life and fear of future suffering frequently were unbearable (89-92%) when symptom intensity was high. Loss
of control over one’s life, vomiting and not being able to do important things frequently were unbearable (52-80%)
when symptom intensity was low. Unbearable weakness significantly increased between pre-final and final
interview. Physical suffering, loss of meaning, loss of autonomy, experiencing to be a burden, fear of future suffering
and worrying more frequently occurred in patients suffering unbearably overall.
Conclusions: Weakness was the most prevalent unbearable symptom in an end-of-life primary care cancer
population. Physical suffering, loss of meaning and loss of autonomy more frequently occurred in patients who
suffered unbearably overall.* Correspondence: c.ruys3@kpnplanet.nl
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Many cancer patients in the end-stage of their disease
prefer to die at home [1,2]. In the Netherlands 45% of all
cancer patients die at home [3]. Palliative care for these
patients is provided by primary care physicians. Of the
remaining cancer deaths 31% occur in hospitals, 19% in
care homes and 4% in hospices. Characteristics of pri-
mary palliative care include selection of patients with a
preference to die at home, palliative care provided by a
physician trained in general medicine, strong relation-
ships between physicians and patients, care provided at
home and dependent upon the possibilities of care at
home, support by a home team, support by a specialized
palliative care service and negative selection of cancer
related emergencies [4-7]. The low prevalence of pa-
tients dying from cancer at home may interfere with ef-
fectively building up experience in palliative cancer care
[8]. Primary care in the Netherlands is provided by
nearly 9.000 general practitioners (GPs), 57% of whom
work part time [9]. A full time GP on average is respon-
sible for palliative care for a cancer patient nearly three
times a year [10].
Suffering in advanced cancer patients [11] may result
in a desire for hastened death, or even a request for eu-
thanasia or physician-assisted suicide [EPAS] [12-16]. In
a few countries and states, including the Netherlands,
EPAS has been legalized [17,18]. EPAS in legalized set-
tings in majority is performed in primary care [18,19]. In
relation to continuing societal and political debate about
end-of-life decision making countries and states may
face reevaluation of the legal position of EPAS [20,21].
The legalization of EPAS in the Netherlands requires
presence of unbearable suffering, which needs to be
assessed present by a physician who considers to per-
form EPAS in reaction to an explicit request for EPAS.
Unbearable and hopeless suffering, no reasonable ac-
ceptable treatment alternative, a voluntary and well-
considered request and consultation of an independent
physician are among the compulsory criteria for EPAS
[17]. EPAS is not permitted if the suffering is not
assessed to be unbearable.
In professional literature the supposition holds that
the proportion of patients who seriously consider EPAS
is small [15,22]. Research seldom addresses unbearable
suffering, nor EPAS, through prospective patient di-
rected research. In the Netherlands in 2010 42.600 pa-
tients died as a consequence of cancer [23], of whom
upon estimation ~ 19.000 (45%) [3] died at home. A
total of ~3550 EPAS (88% of in total 4050 annual cases
of EPAS) was performed in primary care [19] of which
in ~ 2800 cases (cancer is the diagnosis in 79% of cases
of EPAS) the diagnosis was cancer. Thus, of end-of-life
cancer patients cared for in primary care around one in
seven died as a consequence of EPAS. This proportion isconsiderable and underscores the importance for a bet-
ter understanding of the nature of unbearable suffering
in various settings of care, which may contribute to
competently providing care for patients who experience
unbearable suffering.
Unbearable suffering seldom is investigated through
prospective, patient directed research. Intensity of symp-
toms is considered to largely determine the suffering of
incurable cancer patients [24]. However, a symptom that
is unbearable for one person may be bearable for an-
other. A prospective study in end-of-life cancer patients
cared for in primary care was performed, addressing the
following questions: Which are the most prevalent
symptoms? What is the relationship between intensity of
symptoms and unbearable suffering? How do symptoms
and unbearable suffering evolve over time? Which quali-
tative characteristics of unbearable symptoms determine
the nature of unbearable suffering?
Methods
Design
The study was conducted in Utrecht, a city with a popu-
lation of 235 000 people and 105 GPs. Eligible were ter-
minal cancer patients expected to die within six months
and expected to live at home (most of the time) until
death cared for by a GP as the primary responsible phys-
ician. GPs requested eligible patients to participate. GPs
estimated survival based upon signs of clinical deterior-
ation of the patient.
Forty-four GPs, 59% of whom worked part time, repre-
senting 42% of the GPs in the city, with practice loca-
tions dispersed throughout the city, requested eligible
patients to participate. A researcher visited the consent-
ing patients within a week and administered the baseline
interview. Follow-up interviews were every two months,
or sooner if the condition of a patient deteriorated. All
interviews were at the patients’ residence. The recruit-
ment process was organized by a study coordinator. GPs
were personally contacted every two months to identify
newly eligible patients. Baseline characteristics of all eli-
gible patients were registered. The interviewers were a
physiotherapist (the study coordinator) and a GP (CDMR),
both trained in interview techniques. The study protocol
was approved by the Medical Ethics Committee at the VU
University Medical Center. The recruitment process is de-
scribed in detail elsewhere [25].
Study population
Patient recruitment was from May 2003 until May 2006,
and follow-up continued until May 2007. Seventy six out of
148 invited patients (51%) entered the interview study. The
attrition rate was 8%, caused by patients who stopped par-
ticipating after one or more interviews and at the end of
follow-up 8% of the patients were alive, leaving 64 patients
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unexpected rapid physical deterioration (N = 27), consider-
ing participation too burdensome (N= 20) and disliking to
talk (N = 15). Another 110 patients were not invited by the
GP, because unexpected rapid disease progression resulted
in a physical condition too debilitated to sustain an inter-
view. Age, gender and type of cancer did not differ between
the patients in and out of the interview sample. The preva-
lence of seriously depressed mood according to the GP was
significantly lower in the interview sample: 5% versus 23%
in the sample which declined participation and 14% in the
sample which was not asked to participate because of a too
debilitated physical condition [26]. The prevalence of de-
pression was investigated, the results of which have been
published separately; one patient suffered from a definite
major depression [26].
Measurement instrument: State-of-Suffering-V
Quality of life instruments tend to focus on the intensity of
symptoms. Health-related quality of life instruments have
limitations in the context of research in dying patients [27].
No instrument existed to assess unbearable suffering. The
State-of-Suffering-V (SOS-V) was developed [28], an instru-
ment directed at assessing the experience of unbearable
suffering of the whole person [11]. The SOS-V (Additional
file 1) is a patient-driven instrument, which provides quan-
titative assessment of intensity and unbearability of phys-
ical, psychological, social and existential symptoms which
may cause suffering. “Symptoms” refers to medical symp-
toms and circumstances as well as psychological, social and
existential aspects which may cause suffering. This ex-
tended interpretation of symptoms is not uncommon in
psychological research. The SOS-V addresses 69 symptoms
in a framework of five functional domains: (I) medical signs
and symptoms; (II) loss of function; (III) personal aspects;
(IV) environment (psychosocial support, provided care)
and (V) nature and prognosis of the disease [28].
Physical symptoms largely are present in the domain of
medical signs and symptoms. The nature of suffering
caused by a certain symptom cannot be predicted and
therefore an a-priori distinction of suffering into physical,
psychosocial, or existential dimensions cannot be made.
The SOS-V is a structured instrument in which the pa-
tient assesses intensity (or extent) and unbearability per
symptom. A uniform 5-point scoring scale is employed,
supported by a description: 1-not at all; 2-slightly; 3-
moderately; 4-seriously; 5-very seriously, hardly can be
worse. Whenever a patient rates a 4 or 5 for unbearability
of a symptom the interviewer through open-ended ques-
tions shortly further explores the experience and immedi-
ately writes down exact phrases of the answers. After rating
the 69 symptoms the interviewer asks whether there are
missing aspects which cause suffering, and rates these ac-
cordingly if present. Thereafter the patient is asked to rateoverall unbearable suffering, considering all the present
symptoms (same rating scale). Semi-structured administra-
tion of the SOS-V is permitted in the sense that the inter-
viewer may follow a spontaneous other sequence of
symptoms which a patients provides, as long as all symp-
toms are evaluated. The reference period in the study was
the last two days. Limited field testing was performed. The
development of the instrument, including analysis of valid-
ity, is described elsewhere [28]. Administration of the quan-
titative questions of the SOS-V most times was possible
within 15 to 20 minutes [10,28].
Analysis of relationship between intensity of symptoms
and unbearable suffering
The final SOS-V interviews before death in 60 patients
were analyzed to investigate the relationship between in-
tensity of a symptom and experienced unbearable suffer-
ing caused by that symptom. Four patients could not be
evaluated because the interviewer considered the inter-
view to burdensome and abandoned the interview.
Intensity of symptoms and unbearable suffering per
symptom were analyzed dichotomously. A symptom with
intensity rated 2 (slightly) or 3 (moderately) was defined
to be of low intensity, while a symptom rated 4 (seriously)
or 5 (hardly can be worse) was defined to be of high inten-
sity. Symptoms in which unbearability was rated 1 (not at
all), 2 (slightly) or 3 (moderately) were defined to be bear-
able, while symptoms rated 4 (seriously) or 5 (hardly can
be worse) were defined to be unbearable. Overall unbear-
able suffering was defined accordingly. Presence of symp-
toms, intensity of symptoms and unbearability per
symptom are presented as proportions of interviewed pa-
tients. Sample size (many clinically relevant symptoms
were infrequently present) interfered with worthwhile stat-
istical analysis. The relationship between intensity of
symptoms and unbearable suffering is evaluated for the
symptoms which (arbitrarily) were unbearable in at least
15% (n = 9) of the patients.
Analysis of longitudinal data
In 33 patients the SOS-V was administered at least two
times. Intensity of symptoms, consequent unbearable
suffering, and overall unbearable suffering, were ana-
lyzed for the symptoms in which unbearable suffering
occurred most frequently (symptom unbearable in at
least 15% of patients). For dichotomous analysis the
same cut-off scores were used as described above. Confi-
dence intervals for paired data per patient were calcu-
lated for statistical analysis.
Analysis of subjective descriptions of unbearable
suffering
The answers of the patients to open questioning of why the
suffering caused by a symptom was unbearable were
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were compared with patients in whom overall suffering was
unbearable. A schedule was made of senses of suffering
[29] considered important in end-of-life cancer patients
(Table 1) [11,24,29-35]. Common emotional symptoms of
psychological distress of individuals as they approach the
terminal phase of illness [36,37] were additionally analyzed
together. Two raters, a GP (CDMR) and an external clinical
psychologist, rated all the qualitative answers. It was only
permitted to give one rating per unbearable answer: the
best fitting match. The raters started with independently
rating the answers of five patients, after which the answers
were compared. Fine tuning of the rating process was ap-
plied based upon exchange of arguments, after which the
answers of the remaining patients were independently
rated. Then the raters compared all differing ratings and
applied one rating if consensus could be reached. Only
equal ratings were used to compare patients in whom over-
all suffering was bearable with patients in whom overall suf-
fering was unbearable. Consensus between the raters
occurred in 86% of the analyzed descriptions of unbearable
suffering. T-tests for mean prevalence were used for statis-
tical analysis.
In the ratings which remained without consensus it
was analyzed what caused the difference in rating. Based
upon an analytical process two possibilities were identi-
fied. The first was different opinion about interpretation
of the answer. The second was that the answer con-
tained varied information, which made various ratings
applicable. Persistent difference in rating in 9% was at-
tributable to different interpretation of the answers of
the patients. In 5% difference in rating occurred because
the answers contained information which was applicable
to more than one rating.Table 1 Categorization of qualitative data
Category of suffering Indications for assigning category
Physical Medical morbidity, the physical symptom
Loss of meaning Loss of: identity, capacity of self-fulfillme
Loss of autonomy Suffering acknowledged to be caused b
(presence itself of loss of autonomy or o
Loss of dignity Socially embarrassing symptoms, shame
Loss of sexual role Loss of capability of sexual functioning;
Fear of future suffering Fear caused by awareness of potential s
Anxiety Anxiety
Death anxiety Anxiety related to awareness of the pro
related to the actual dying process
Depressiveness Suffering caused by the presence of dep
Worrying Negative thoughts which cannot be tur
Feeling tensed Feeling tensed in mind or body
Hopelessness Loss of possibility of meaning
Pointlessness Total loss of meaning; nothing leftResults
Study sample
The studied sample consisted of 60 patients; 46 patients
died within six months. The final interview on average
was 30 days before death (SD 17 days); in 23% the inter-
view was within 2 weeks prior to death. The average age
of the patients was 70 years (range 38–86), 52% were fe-
male, 60% were educated beyond elementary school,
63% were living alone, 77% had children and 62% were
religious (protestant or catholic). The most prevalent ma-
lignancies were lung cancer (27%) and gastro-intestinal
cancer (25%).
Symptom prevalence and unbearable suffering
Symptom prevalence was highest in the domains of med-
ical symptoms, loss of function and personal aspects
(Tables 2 and 3). Weakness was the most prevalent symp-
tom in the domain of medical symptoms (93%), and was
unbearable in 57% of the patients. Other prevalent symp-
toms were tiredness, general discomfort, changed appear-
ance and pain (72-87%). Pain was unbearable in 25%.
Most prevalent in the functional domain were impaired
routine daily activities and impaired leisure activities (just
above 80%), which were unbearable in half of the patients.
Most prevalent in the domain of personal aspects was
feeling dependent upon others (80%), which was unbear-
able in 45% of patients. Other prevalent symptoms were
not being able to do important things and trouble accept-
ing the present situation (around 60%). Loss of control
over one’s life was sensed in 30% of patients and was un-
bearable in 27%. In the domain of environment the feeling
that relatives considered the suffering too severe occurred
in 33%. In the domain of nature and prognosis of disease
fear of future suffering occurred in 40%.itself, physical symptoms which result in physical experienced suffering
nt, communication, social role, social interaction, intimacy
y: loss of autonomous functioning or occurrence of dependency
f dependency is not sufficient to assign the category)
, body image concerns, not being taken seriously, worthlessness
loss of sexual role
uffering related to progress of disease
cess of dying and what will go along with that, and anxiety
ressive thoughts
ned off



















Weakness 93 (56) 51 (31) 43 (26) 84 42 (25) 14 (8) 32 57 (34)
Tiredness 87 (52) 48 (29) 28 (17) 59 39 (23) 7 (4) 17 35 (21)
General discomfort 80 (48) 27 (16) 17 (10) 63 53 (32) 20 (12) 38 37 (22)
Changed
appearance
78 (47) 40 (24) 20 (12) 50 38 (23) 2 (1) 4 22 (13)
Pain 72 (43) 20 (12) 18 (11) 92 52 (31) 7 (4) 13 25 (15)
Loss of appetite 62 (37) 24 (14) 10 (6) 43 38 (23) 15 (9) 39 25 (15)
Shortness of
breath
59 (35) 17 (10) 14 (8) 80 42 (25) 5 (3) 12 19 (11)
Impaired
co-ordination
57 (34) 17 (10) 13 (8) 80 40 (24) 5 (3) 13 18 (11)
Not sleeping well 47 (28) 12 (7) 10 (6) 86 35 (21) 15 (9) 43 25 (15)
Thirst 45 (27) 18 (11) 10 (6) 55 27 (16) 2 (1) 6 12 (7)
Feeling tensed 44 (26) 12 (7) 10 (6) 86 32 (19) 2 (1) 5 12 (7)
Memory loss 43 (26) 12 (7) 7 (4) 57 32 (19) 8 (5) 26 15 (9)
Impaired sight 42 (25) 5 (3) 3 (2) 67 37 (22) 4 (2) 9 7 (4)
Impaired mental
clarity
42 (25) 10 (6) 5 (3) 50 32 (19) 7 (4) 21 12 (7)
Loss of
concentration
40 (24) 13 (8) 12 (7) 88 27 (16) 5 (3) 19 17 (10)
Coughing 38 (23) 2 (1) 2 (1) 100 36 (22) 3 (2) 9 5 (3)
Swallow food
impaired
35 (21) 7 (4) 7 (4) 100 28 (17) 5 (3) 18 12 (7)
Smelling
unpleasant
35 (21) 8 (5) 8 (5) 100 27 (16) 3 (3) 19 13 (8)
Feeling depressed 34 (20) 3 (2) 2 (1) 50 31 (18) 10 (6) 33 12 (7)
Impaired hearing 33 (20) 8 (5) 7 (4) 80 25 (15) 8 (4) 27 13 (8)
Incomprehensible
speech
32 (19) 14 (8) 12 (7) 88 18 (11) 3 (2) 18 15 (9)
Itch 32 (19) 8 (5) 5 (3) 60 24 (14) 2 (1) 7 7 (4)
Constipation 30 (18) 8 (5) 8 (5) 100 22 (13) 4 (2) 15 12 (7)
Nausea 28 (17) 12 (7) 8 (5) 71 16 (10) 5 (3) 30 13 (8)



















Table 2 Relationship between symptom intensity and unbearability for symptoms in the domain of: medical signs and symptoms (n = 60) (Continued)
Vomiting 27 (16) 9 (5) 7 (4) 80 18 (11) 13 (8) 73 20 (12)
Feeling anxious 27 (16) 5 (3) 3 (2) 67 22 (13) 4 (2) 15 7 (4)
Swallowing fluid
impaired
23 (14) 5 (3) 5 (3) 100 18 (11) 2 (1) 9 7 (4)
Hiccups 22 (13) 7 (4) 5 (3) 75 15 (9) 5 (3) 33 10 (6)
Intestinal cramps 22 (13) 5 (3) 3 (2) 67 17 (10) 5 (3) 30 8 (5)
Diarrhea 20 (12) 3 (2) 3 (2) 100 17 (10) 4 (2) 20 7 (4)
Incontinence of
urine
10 (6) 0 (0) 0 (0) 0 10 (6) 0 (0) 0 0 (0)
Incontinence of
feces
8 (5) 2 (1) 2 (1) 100 6 (4) 5 (3) 75 7 (4)




7 (4) 2 (1) 2 (1) 100 5 (3) 1 (1) 33 3 (2)
Paralyzed limbs 5 (3) 2 (1) 2 (1) 100 3 (2) 0 (0) 0 2 (1)
Skin metastasis 3 (2) 3 (2) 2 (1) 50 0 (0) 0 (0) 0 2 (1)
Rounded percentages and absolute numbers; between 0 to 1 missing observations per symptom.
Scoring: 1-not at all; 2-slightly; 3-moderately; 4-seriously; 5-very seriously, hardly can be worse.
Symptom present: intensity scores 2–5.
Low intensity: scores 1–3; High intensity: scores 4–5; Bearable suffering: scores 1–3; Unbearable suffering: scores 4–5.
*: percentage of interviewed patients followed up until death.



















Table 3 Relationship between symptom intensity and unbearability in the domains of loss of function, personal aspects, environment, nature and prognosis














when low intensity %
Symptom
unbearable %*(n)




83 (50) 58 (35) 48 (29) 83 25 (15) 7 (4) 27 55 (33)
Impaired leisure activities 82 (49) 60 (36) 48 (29) 81 22 (13) 2 (1) 8 50 (30)
Help needed with
housekeeping
71 (42) 54 (32) 39 (23) 72 17 (10) 3 (2) 20 42 (25)
Help needed with
self-care
60 (36) 27 (16) 15 (9) 56 33 (20) 7 (4) 20 22 (13)
Bedridden 56 (33) 32 (19) 24 (14) 74 24 (14) 8 (5) 36 32 (19)
Impaired working
capacity
17 (10) 17 (10) 12 (7) 70 0 (0) 0 (0) 0 12 (7)
Impaired sexual
functioning





80 (48) 50 (30) 37 (22) 73 30 (18) 8 (5) 28 45 (27)
Not able to do things
you consider important
63 (36) 26 (15) 23 (13) 87 37 (21) 19 (11) 52 42 (24)
Trouble accepting the
present situation
60 (36) 30 (18) 25 (15) 83 30 (18) 8 (5) 28 33 (20)
Feeling a nuisance to
others
38 (23) 5 (3) 3 (2) 67 33 (20) 10 (6) 30 13 (8)
Negative thoughts or
worrying
32 (19) 12 (7) 8 (5) 71 20 (12) 7 (4) 33 15 (9)
Loss of control over your
own life
30 (18) 22 (13) 20 (12) 92 8 (5) 7 (4) 80 27 (16)
Feeling not any longer
being the same person
28 (17) 8 (5) 8 (5) 100 20 (12) 2 (1) 8 10 (6)




22 (13) 5 (3) 0 (0) 0 17 (10) 8 (5) 50 8 (5)
Feelings of
worthlessness



















Table 3 Relationship between symptom intensity and unbearability in the domains of loss of function, personal aspects, environment, nature and prognosis
of disease (n = 60) (Continued)
Feeling lonely
(intrapersonal)
20 (12) 5 (3) 3 (2) 67 15 (9) 7 (4) 44 10 (6)
Feeling of no longer
being important to
others
18 (11) 5 (3) 5 (3) 100 13 (8) 3 (2) 25 8 (5)
Feeling tired of life 17 (10) 5 (3) 5 (3) 100 12 (7) 4 (2) 29 9 (5)
Not satisfied with own
self
12 (7) 5 (3) 5 (3) 100 7 (4) 2 (1) 25 7 (4)
Feelings of guilt 12 (7) 2 (1) 2 (1) 100 10 (6) 3 (2) 33 5 (3)
Experienced little success
in life
10 (6) 2 (1) 0 (0) 0 8 (5) 2 (1) 20 2 (1)
Lived a life with little
purpose





33 (19) 10 (6) 9 (5) 83 23 (13) 7 (4) 31 16 (9)
Practical loneliness (no
one present for you)
15 (9) 8 (5) 8 (5) 100 7 (4) 4 (2) 50 12 (7)
Insufficient availability of
care
12 (7) 2 (1) 0 (0) 0 10 (6) 8 (5) 83 8 (5)
Unsatisfactory social
contacts
8 (5) 2 (1) 2 (1) 100 6 (4) 1 (1) 25 3 (2)
Insufficient support
(family, relatives)
5 (3) 0 (0) 0 (0) 0 5 (3) 2 (1) 33 2 (1)
Shame 2 (1) 0 (0) 0 (0) 0 2 (1) 2 (1) 100 2 (1)
Domain V: Nature and
prognosis of disease
Fear of future suffering 40 (24) 15 (9) 14 (8) 89 25 (15) 3 (2) 13 17 (10)
Fear of future failing
strength to bear
suffering
25 (15) 8 (5) 8 (5) 100 17 (10) 2 (1) 10 10 (6)
Rounded percentages and absolute numbers; 0 to 3 missing observations per symptom. Impaired working capacity applied for 10 persons.
Scoring: 1-not at all; 2-slightly; 3-moderately; 4-seriously; 5-very seriously, hardly can be worse.
Symptom present: intensity scores 2–5.
Low intensity: scores 1–3; High intensity: scores 4–5; Bearable suffering: scores 1–3; Unbearable suffering: scores 4–5.
*: percentage of interviewed patients.
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Analysis of the relationship between intensity of symptoms
and consequent unbearability for the most prevalent
unbearable symptoms (25 symptoms were unbearable in
at least 15%) demonstrated that high intensity of symp-
toms most frequently resulted in unbearable suffering
for pain, loss of control over one’s life, fear of future
suffering, not being able to do important things and
not sleeping well (86-92%). Low intensity of symp-
toms most frequently resulted in unbearability for loss
of control over one’s life (80%), vomiting (73%), not
being able to do important things (52%), not sleeping
well (43%) and loss of appetite (39%).
Intensity of symptoms and unbearable suffering
longitudinally
In 33 patients the SOS-V was administered at least two
times. The pre-final interview on average was 123 days be-
fore death (SD 47 days). Prevalence of high symptom inten-
sity significantly increased in the period between pre-final
and final interview for general discomfort, being bedridden
and help needed with self care (Table 4). Prevalence of un-
bearable suffering significantly increased for weakness.
The nature of suffering: analysis of the qualitative data
Examples of qualitative answers of patients are provided in
Table 5. The process of analysis of the qualitative data is
demonstrated in Table 6. Overall unbearable suffering oc-
curred in 28 percent (n = 16) of patients interviewed with
the SOS-V. No significant difference in age, gender and
cancer type occurred for present or absent overall unbear-
able suffering. The qualitative answers of the patients indi-
cated physical suffering to be responsible for unbearable
suffering with a mean of 4,0 in patients with overall unbear-
able suffering versus 2,1 in patients with overall bearable
suffering (Table 7). Loss of meaning was present with a
mean of 3,6 in patients with overall unbearable suffering,
versus 2,0 in patients without overall unbearable suffering,
while for loss of autonomy the mean numbers were 3,1 ver-
sus 2,2. All of these differences were statistically significant.
Fear of future suffering and worrying were less prevalent
overall, yet also went along with a mean higher number in
patients with overall unbearable suffering. A remarkable re-
petitive explanation of unbearability of loss of appetite was
the unwanted consequence of further loss of strength, re-
lated to not being able to eat.
Discussion
The present study in end-of-life cancer patients in the
home setting and in the care of primary care physicians
demonstrated that weakness was the most prevalent phys-
ical symptom (93%), which was unbearable in approxi-
mately half of the patients. Pain was present in 72% of
patients and was unbearable in a quarter of patients. Alarge variety of symptoms was present. If symptoms were
of high intensity than unbearability frequently occurred
for pain, loss of control, fear of future suffering, not being
able to do important things and not sleeping well (86-
92%). If symptoms were of low intensity than unbearabil-
ity frequently occurred for loss of control, vomiting, not
being able to do important things, not sleeping well and
loss of appetite (39-80%). The prevalence of symptom in-
tensity increased significantly between on average four
months before death and on average one month before
death for general discomfort, being bedridden and help
needed with self care; the prevalence of unbearability sig-
nificantly increased for weakness. Intensity and unbearabil-
ity of pain were unchanged in the longitudinal follow-up.
Evaluation of the qualitative study outcomes demonstrated
that physical suffering, loss of autonomy, loss of meaning,
fear of future suffering, experiencing to be a burden to
others and worrying were significantly more prevalent in
patients with overall unbearable suffering. The combined
emotional symptoms of psychological distress were higher
in patients with overall unbearable suffering.
Strengths and limitations
The study was realized despite relevant barriers to re-
search of end-of-live cancer patients in primary care
(low prevalence of the studied patients, geographical dis-
persed setting of patients, physicians and researchers,
difficulty of recruitment of end-of-life cancer popula-
tions for research) [25]. The 51% recruitment proportion
of requested patients is comparable to recruitment pro-
portions in secondary care studies investigating end-of-
life cancer patients [10].
The study has limitations. The small sample size inhib-
ited significant statistical analysis of the data of the rela-
tionship between intensity of symptoms and unbearability.
Unexpected rapid physical deterioration limited the num-
ber of interviews shortly before death. The study sample
concerns a Western population of patients in a specific
setting of care, which limits generalizability.
Comparison to other studies
No quantitative studies of unbearable suffering were
found. Two studies qualitatively investigated unbearable
suffering in mixed diagnostic populations (also other diag-
noses than cancer) and identified physical, psychosocial
and existential themes which contributed to the suffering
[38,39]. In end-of-life cancer patients in secondary care
overall moderate to extreme suffering was reported
present in a range of 25%-81% [11,40,41], with physical
symptoms, psychological distress and existential concerns
contributing to the suffering [11]. The prevalent physical
symptoms in this study, such as weakness, tiredness, gen-
eral discomfort, changed appearance, pain and loss of ap-
petite, are also prevalent in secondary care studies [24].
Table 4 Development of intensity and unbearability of symptoms between the pre-final and final interview in patients with at least two interviews (n = 33)*
Symptom in high intensity† Symptom unbearable†
Pre-final interview % (n) Final interview
% (n)
Difference pre-final and final





Difference pre-final and final
interview % (95% CI) ‡
Domain I: Medical symptoms
Weakness 36 (12) 55(18) −18 (−29 to 3) 33 (11) 64(21) −30 (−41 to −6)
General discomfort 9 (3) 27(9) −18 (−19 to −1) 25 (8) 42(14) - 16 (−33 to 9)
Tiredness 39 (13) 55(18) −15 (−29 to 7) 42 (14) 42(14) 0 (−16 to 16)
Loss of appetite 27 (9) 18(6) 9 (−11 to 23) 27 (9) 36(12) −9 (−26 to 13)
Pain 24 (8) 21(7) 3 (−11 to 14) 24 (8) 27(9) −3 (−20 to 16)
Not sleeping well 12 (4) 6(2) 6 (−10 to 17) 9 (3) 24(8) −15 (−26 to 5)
Changed appearance 30 (10) 42(14) −12 (−29 to 11) 30 (10) 24(8) 6 (−12 to20)
Shortness of breath 6 (2) 21(7) −15 (−15 to 0) 12 (4) 21(7) −9 (−23 to 11)
Vomiting 3 (1) 12(4) −9 (−9 to 4) 9 (3) 18(6) −9 (−15 to 7)
Impaired co-ordination 12 (4) 12(4) 0 (−14 to 14) 24 (8) 18(6) 6 (−16 to 25)
Loss of concentration 21 (7) 9(3) 12 (−5 to 18) 16 (5) 18(6) −3 (−18 to 14)
Memory loss 15 (5) 9(3) 6 (−7 to 12) 19 (6) 18(6) 0 (−11 to 11)
Incomprehensible speech 3 (1) 12(4) −9 (−15 to 7) 9 (3) 9(3) 0 (−11 to 11)
Domain II: Loss of function
Impaired routine daily activities 49 (16) 67(22) −18 (−35 to 7) 55 (18) 61(20) −6 (−27 to 18)
Impaired leisure activities 49 (16) 64(21) −15 (−26 to 5) 42 (14) 52(17) −9 (−15 to 6)
Help needed with housekeeping 39 (13) 55(18) −15 (−29 to 7) 42 (14) 39(13) 3 (−16 to 10)
Bedridden 12 (4) 36(12) −24 (−30 to −5) 18 (6) 36(12) −18 (−24 to 1)
Help needed with self-care 6 (2) 27(9) −21 (−27 to −1) 15 (5) 30(10) −15 (−25 to 5)
Domain III: Personal aspects
Not able to do important things 39 (13) 31(10) 9 (−11 to 24) 39 (13) 55(18) −15 (−26 to 5)
Feeling dependant on others 33 (11) 55(18) −21 (−32 to 1) 39 (13) 52(17) −11 (−23 to 8)
Trouble accepting situation 21 (7) 36(12) −15 (−26 to 5) 27 (9) 39(13) −12 (−26 to 9)
Loss of control over own life 9 (3) 21(7) −12 (−23 to 7) 16 (5) 30(10) −13 (−23 to 8)



















Table 4 Development of intensity and unbearability of symptoms between the pre-final and final interview in patients with at least two interviews (n = 33)*
(Continued)
Domain IV: Environment
Relatives: suffering to severe 9 (3) 9(3) 0** 12 (4) 15(5) −3 (−9 to 7)
Domain V: Nature and prognosis of disease
Fear of future suffering 9 (3) 12(4) −3 (−14 to 11) 13 (4) 12(4) 0 (−11 to 11)
Overall unbearable suffering 13 (4) 33(11) −20 (−27 to 1)
* Selection of most frequent unbearable symptoms: symptoms which were unbearable (score 4 or 5) in at least 15% (9 patients) in the last interview for all patients with at least one interview; between 0–2 missing
observations per symptom; three missing observations for overall unbearable suffering.
† High intensity: score 4 or 5 for intensity according to SOS-V; unbearable: score 4 or 5 for unbearability according to SOS-V.
‡ 95% confidence intervals calculated taking into account that results for pre-final and final interview are paired per patient; significant outcomes (0 outside of confidence interval) presented in bold.



















Table 5 Personal descriptions of unbearable suffering by patients with high scores (score 4 or 5) on the SOS-V in the
ultimate interview
General discomfort: You just feel miserable, it feels like a sort of flue, you don’t fancy doing anything, you only want to lie in bed
Tired: I hardly can do anything, it is nearly impossible to explain it in words, I never imagined a person could be so
tired
Weakness: My right leg is to weakened, it is not safe to stand and so for weeks I lie in my bed all the time and only come out
for the latrine chair
Not sleeping well: There is the noise at night on the streets, ambulances passing by, and this screaming neighbor woman, who
keeps the whole neighborhood awake
Pain: I have pain all day, it occupies my mind, there is little distraction
Loss of appetite: I can hardly any more enjoy the taste of food, I long for the flavor of a fine stew
Thirst: My mouth is dry, I need to drink, but this makes me nauseous
Smelling unpleasant: I hate this urine smell
Changed appearance: I used to be vain, now I have become so thin, I find it ugly looking at my neck
Impaired mental clarity: I think about something, and then it’s gone, I find that stupid, for instance when I am one my way to fetch
something
Concentration loss: My mind loses its way, I find this unpleasant
Memory loss: I used to remember all by mind, because I am illiterate
Feel tense: I try to control it, for the children
Feel depressed: This depressed mood in itself is unpleasant; at the same time it grows, because my daughter is doing less well
Feel anxious: I feel afraid for what will come and worry about how things will go on for my wife
Shortness of breath: Even with only slight activity I have a sort of hyperventilation, which makes me anxious
Coughing: When in public, than this phlegm comes out in my handkerchief, it’s very annoying
Obstruction to swallow food: I need to feed myself to prevent becoming even more weakened, but the passage of food is deranged
Obstruction to swallow fluid: I swallow, but it doesn’t pass, it makes me retch
Nausea I am nauseous continuously, I feel completely fed up with it
Vomiting: When I sit at the table, it suddenly comes up and I need to run for the bathroom
Constipation: It hurts and is strenuous
Diarrhea: You are dining out in a hotel and then you continuously need to go to the toilet
Intestinal cramps: These cramps are painful, it is very unpleasant
Incontinence of urine: X (no high scores in ultimate interview)
Incontinence of feces: It is filthy
Hiccups: It comes sudden and unexpected, it makes me feel uncivilized and ashamed
Pressure ulcers: It is annoying
Itch: You keep on scratching
Skin metastasis: In my neck, after radiotherapy it turned yellow, with an unpleasant look, it smells
Paralyzed limbs: I can’t do anything, my left leg is paralyzed and my arm is forceless
Impaired coordination: These unpredictable cramps and shaking of an arm or a leg, I cannot stop it
Incomprehensible speech: I cannot communicate by telephone, people don’t understand what I am saying
Impaired comprehension of
speech:
It makes me feel stupid
Dizziness: Sometimes it is frightening, one time it happened when my alarm-button was out of reach and it took a whole
long time before anybody entered and took notice
Impaired sight: It annoys me so much, it is caused by the medication
Impaired hearing: If some people talk at the same time I cannot differentiate what is being said
Impaired working capacity: I am already counted out in society
Impaired in routine daily
activities:
I am not the crying type, but this week I suddenly started crying
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Table 5 Personal descriptions of unbearable suffering by patients with high scores (score 4 or 5) on the SOS-V in the
ultimate interview (Continued)
Impaired leisure activities: I used to go out, make bus trips, I miss it, but absolutely can’t do it anymore. And I can’t any more receive people
at my home, I am to exhausted
Need help with housekeeping: Being young and not capable to function independently, it feels so unnatural
Need help with self-care: I don’t want these young maidens of the home care service, it makes me feel ashamed
Pedridden: More and more you are drawn to that bed, it makes you realize you are deteriorating
Restricted sexual functioning: Widower: I feel rejected by my present partner, there is no intimacy, it is so cold
Not satisfied with own self: I just left my wife, she had done nothing wrong, life than takes a course, leaving impossible to restore the situation
Lived a life with little purpose: With my first wife everything was fine, the last years I miss love and tenderness
Experienced little success in life: I would have liked to be at a somewhat higher level in society, for instance I would have liked to study, I would do
it differently if I could do it again
Little happiness with family/
close ones:
I would have preferred things to be different, I haven’t seen my children for 18 years
Trouble accepting situation: I can no longer play Chopin, or make a drawing
Negative thoughts or worrying: I would have liked to do things differently, at night it appears in my dreams
Feelings of guilt: I feel guilt I wanted to divorce from my wife the other year, she is the one who makes I am still living now, she
does everything for me
Feel worthless: There is no more appreciation, people talk about you and not with you
Feel lonely: One has cancer, it is not contagious, but people pass by less frequently
Feel hopeless: This is not what I want
No longer feel the same
person:
Is this the same body? Yet I have to manage with it, which causes me trouble
Feel tired of life: I prefer it to be over as soon as possible, I used to be very active and independent and now I am totally passive
and dependant
Feel dependant of others: Ones individuality is lost, one has no more privacy
Feeling loss of control of life: Tears in the eyes, gives no answer
Feeling a nuisance to others: In relation to being so dependant I now easily tend to think “Oh, just leave it”
Feel unimportant to others: My daughter, she is very sick and I can’t do anything for her
Impossible to do important
things:
I used to daily visit my wife in a nursing-home, I can’t do it any longer
Not supported sufficiently by
close ones:
The physical support is O.K., but there is emotional shortage
Lonely (important people
absent):
I have one son, he does not visit me
Feelings of shame: I have these outburst directed at my own person, which I find alarming, than this tic of my jaw appears and I
wonder whether I can appear this way in church
Relatives consider your
suffering severe:
It makes it difficult to start a conversation
Unsatisfactory contact with
close ones:
They don’t keep stand up to their promises, for instance my daughter promises to visit me next week, I look
forward to see her and then she shows up 1,5 years later
Insufficient availability of care: I find the home care miserable
Fear of future suffering: I feel short of breath, I am afraid to suffocate
Fear losing strength to bear the
suffering:
To die, would it be painful?
Personal additions of missing
aspects:
The hospice refused me last week, they considered me too good and advised a nursing home
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Palliative home care has to meet the challenge of reducing
unbearable suffering in end-of-life cancer patients. Be-
tween countries substantial differences in organization ofpalliative home care exist [2]. Palliative home care is pro-
vided in various models, such as general practitioner deliv-
ered palliative care [4,42] and home-based hospice care
[43,44]. The services provided within these models are not
Table 6 Symptom, description of what makes the symptom unbearable and rated category; examples
Symptom Description of unbearability by patient Rated category
Tired? I hardly can do anything, it is nearly impossible to explain it in words.
I never imagined a person could be so tired
Physical
Lonely (important people absent)? I have one son, he does not visit me Loss of meaning
Feel dependant on others? I used to be very independent, and do all myself.
Now I need to ask for everything, or wait.
Loss of autonomy
Hiccups? It comes sudden and unexpected, it makes me feel uncivilized and ashamed Loss of dignity
Feel to be a burden to others? My husband, he needs to care for me continuously Burden to others
Restricted sexual functioning? It is gone, it is in pieces, not only for myself, but also for my wife Loss of sexual role
Fear of future suffering? I am in fear of suffering pain, that the pain will be unbearable Fear of suffering
Nausea? I feel panic. Am I going to vomit? Is it going to be difficult to breathe?
Is it going to happen when I am eating?
Anxiety
Fear of future suffering? I am frightened to suffocate Death anxiety
Feel depressed? This depressed mood in itself is unpleasant, at the same time it grows,
because my daughter is doing less well
Depressive thoughts
Negative thoughts, worrying? It haunts my mind all day: dissemination of cancer to my liver, 2 to 3 months to live.
An operation? Other possibilities?
Worrying
Feel tensed? To be able to be more relaxed would help me; now it makes me lose much energy Feeling tensed
Hopelessness? To take up a piece of paper , I can’t manage it, I cannot stand it Hopelessness
Trouble accepting present situation? The fact that it is as it is, to look it in the face. It is over, I am just waiting Pointlessness
Table 7 Categories of suffering for patients who did or did not experience overall unbearable suffering (results from
coding of open questions on why aspects of the SOS-V were unbearable)





Mean number in which




Mean number in which




Physical suffering 100 (16) 4.0 (2.1) 61 (25) 2.1 (2.4) 0.008
Loss of meaning 88 (14) 3.6 (3.3) 63 (26) 2.0 (2.1) 0.027
Loss of autonomy 88 (14) 3.1 (2.2) 44 (18) 2.2 (1.6) 0.003
Loss of dignity 56 (9) 1.1 (1.5) 32 (13) 0,5 (0.9) 0.064
Experience to be a
burden to others
56 (9) 0.7 (0.7) 17 (7) 0.2 (0.5) 0.025
Loss of sexual role 6 (1) 0.1 (0.3) 2 (1) 0.02 (0.2) 0.491
Fear of future
suffering
44 (7) 0.8 (0.9) 5 (2) 0.04 (0.2) 0.009
Anxiety 31 (5) 0.6 (1.2) 7 (3) 0.1 (1.3) 0.089
Death anxiety 6 (1) 0.1 (0.5) 0 (0) 0.0 (0.0 0.333
Depressive thoughts 19 (3) 0.2 (0.4) 2 (1) 0.02 (0.2) 0.134
Worrying 44 (7) 0.5 (0.6) 5 (2) 0.1 (0.3) 0.020
Feeling tensed 13 (2) 0.1 (0.3) 5 (2) 0.05 (0.2) 0.417
Hopelessness 19 (3) 0.2 (0.4) 2 (1) 0.02 (0.2) 0.134
Pointlessness 13 (2) 0.4 (1.1) 2 (1) 0.4 (0.5) 0.299
Emotional
symptoms
75 (12) 2.1 (2.6) 20 (8) 0.3 (0.8) 0.014
%: percentage of patients.
n: number of patients.
stdev: standard deviation.
Emotional symptoms of psychological distress: anxiety, death anxiety, depressive thoughts, worrying, feeling tensed, hopelessness and pointlessness.
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sity of palliative home care delivery in the last months of a
patient’s life [46]. Transitions from oncology care to pallia-
tive care may influence patient well-being [47-49]. Pallia-
tive care is an accomplished formal medical specialization
in some countries [50,51], providing possibility of struc-
tural integration of specialist palliative care within various
health care settings, and providing possibility of educa-
tional fellowship rotations for various medical health
specialties. In the Netherlands palliative care is not a
specialty. Psycho-oncologic interventions provided by
mental health professionals have been tested in various
cancer populations [35,52-57]. Yet, for bed-ridden end-of-
life cancer patients at home the contributions of psycho-
oncologic interventions hardly are found applied or tested.
In the Netherlands legalized EPAS, with the compul-
sory criterion of unbearable suffering, most frequently
concerns end-of-life cancer patients in primary care. It
therefore appears that unbearable suffering prevalently is
experienced in end-of-life cancer patients cared for in
primary care. However, in the absence of studies it must
be acknowledged that it is unknown which part of un-
bearably suffering patients die as a consequence of
EPAS, nor is it clear which are the decisive steps from
unbearable suffering to EPAS. Some specific situations
in primary palliative care may influence suffering. Pa-
tients referred back from oncology care to home care,
after hearing that no more treatment remains to slow
down progress of cancer, may be demoralized [31]. Pref-
erence of cancer patients to die at home may inhibit in-
terventions which require the setting of secondary care.
In primary care selection occurs of patients with an ex-
plicit request for EPAS as a consequence of referrals by
secondary care physicians of patients with a request for
EPAS to their primary care physician. The frequency of
these informal referrals is unknown. Mechanisms of
transference and counter-transference about coping with
suffering may be more prominent in primary care as a
consequence of strong patient-physician relationships
[58-61]. Further dynamics of care alter once a decision is
made to proceed in a process towards EPAS [20,62].
Our study demonstrates many physical and psycho-
social symptoms in end-of-life cancer patients cared for in
primary care. Weakness was the most prevalent unbear-
able symptom. End-of-life cancer patients, in the home
setting more than in hospital, may be confronted with loss
of social role and autonomous functioning due to weak-
ness. Pain, a potent cause of suffering [63,64], was unbear-
able in a relevant proportion of patients. The qualitative
evaluation of the study indicates that core qualities of suf-
fering were significantly more prevalent in patients who
experienced overall suffering to be unbearable.
The results of our study underscore the need of ad-
equate symptom control combined with psycho-oncologicinterventions. Adequate control of adverse physical symp-
toms [65] makes it easier to address patients’ concerns
about their families, about their own psychological integ-
rity, and about meaning in their lives [30]. Existential as-
pects of suffering are addressed by psycho-oncologic
interventions directed at meaning [29,53,57] and dignity
[35,54]. Other types of interventions address acceptance
and reactive emotional states [55,56]. Strength provided
by the patient-physician relationship is another quality
which may provide recovery from suffering [29,59,66,67].
The present study also shows that high intensity of symp-
toms does not necessarily indicate suffering, while low in-
tensity of symptoms indeed may be unbearable.
We conclude that end-of-life cancer patients in pri-
mary care must cope with physical symptoms, loss of
meaning, the emotional impact of suffering and the poor
prognosis. Primary care physicians, as part of education
in palliative care, therefore should be trained in under-
standing and diagnosing the multiple dimensions of suf-
fering. The use of a framework of domains of suffering
provides structure in assessment of suffering. It is not
enough to assess the suffering: when meeting patients
and taking their history, clinicians should keep a mental
log of the issues that can be improved [47].
Further studies, as to improve understanding and de-
velop interventions, should address unbearable suffering
in various settings of care and investigate which are de-
cisive steps from unbearable suffering to EPAS.Ethical approval
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